Streetbeat News

Equity Actions

RAPT

Rapt Therapeutics announced a workforce reduction of 47 people, approximately 40% of its existing headcount. The company estimates it will incur around $0.9 million in restructuring charges.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:05 pm

QXO

QXO has closed a $3.5 billion private placement and expects to have $5 billion in cash and no debt after a new $620 million private placement closes on July 25. Additionally, Jared Kushner has joined the company's Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:03 pm

PHM

PulteGroup has announced that Jim Ossowski will be the new CFO, succeeding Bob O'Shaughnessy, who will retire at the end of 2025.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:02 pm

DQ

TAN

Daqo New Energy Corp. (NYSE:DQ) shares are trading higher premarket after the company approved a $100 million share repurchase program, effective until June 30, 2025. The program will be funded from the company's existing cash balance of $2.7 billion. Investors can also gain exposure to the stock via Invesco Solar ETF (NYSE:TAN).

Portfolio Pulse from Lekha Gupta

July 22, 2024 | 12:00 pm

ITRM

Iterum Therapeutics (NASDAQ: ITRM) has commenced a rights offering, distributing subscription rights to shareholders and eligible warrant holders to purchase 8,503,800 units at $1.21 per unit. This move aims to support the development of next-generation antibiotics.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:43 am

DQ

Daqo New Energy shares are trading higher following the announcement of a $100 million share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:53 am

CLRB

Cellectar Biosciences (NASDAQ:CLRB) has generated $19.4M through the exercise of Tranche B warrants and the purchase of new warrants, with the potential to generate an additional $73.3M if the new warrants are exercised.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:52 am

DQ

Daqo New Energy has announced a $100 million share buyback program, which will be effective through June 2025.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:38 am

VSTO

Vista Outdoor reaffirmed its FY25 sales guidance of $2.665B-$2.775B, with Q1 sales expected to be $272M-$276M, significantly below the $674M estimate. The company also disclosed plans for a $50M share repurchase program for Revelyst.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 10:06 am

ARKK

ARKW

TSLA

Cathie Wood's Ark Invest sold $12.24 million worth of Tesla shares ahead of Tesla's Q2 earnings report. Despite the sale, Tesla remains the top holding in Ark's flagship ETF, ARKK. Analysts expect Tesla's earnings per share to drop significantly compared to last year.

Portfolio Pulse from Shanthi Rexaline

July 22, 2024 | 9:47 am